ADMA News and Press, ADMA Biologics Inc From 02/14/26

2026-02-14 13:10:19 ET On February 13, 2026, Ranger Investment Management, L.P. disclosed a buy of 197,073 shares of Solaris Energy Infrastructure (NYSE:SEI) , an estimated $9.53 million trade based on quarterly average pricing. According to a filing with the Securities and Ex...

2026-01-14 09:17:13 ET ... Read the full article on Seeking Alpha For further details see: ADMA Biologics: Business Update And My Price Target

2026-01-12 16:16:00 ET ADMA Biologics, Inc. (ADMA) 44th Annual J.P. Morgan Healthcare Conference January 12, 2026 12:45 PM EST... Read the full article on Seeking Alpha For further details see: ADMA Biologics, Inc. (ADMA) Presents at 44th Annual J.P. Morgan Healthcare Confer...

2026-01-12 08:28:07 ET More on ADMA Biologics The Play On ADMA Biologics: A Discounted Stock With Good Prospects ADMA Biologics: Why The Dip To $16 Resets The Buy Case ADMA Biologics, Inc. (ADMA) Q3 2025 Earnings Call Transcript ADMA signals $1.1B+ 2029 reven...

FY 2025 Preliminary Unaudited Total Revenue of Approximately $510–511 Million Meets or Exceeds Prior Guidance Previously Provided FY 2025 Adjusted EBITDA (1) and Adjusted Net Income (2) Guidance Reiterated Year-End 2025 Cash Grew to Approximately $88 Million with an Unaudited Ope...

RAMSEY, N.J. and BOCA RATON, Fla., Jan. 05, 2026 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), a U.S.-based, end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty biologics, ...

2025-12-12 17:02:32 ET I am circling back ADMA Biologics ( ADMA ) I last looked at this intriguing biotech concern in early August following Q2 results . I am revisiting ADMA Biologics as the company posted Q3 numbers and provided guidance that further confirms that ...

2025-11-20 16:35:23 ET Introduction My last look at ADMA Biologics ( ADMA ) followed its Q4 2024 earnings report in March.... Read the full article on Seeking Alpha For further details see: ADMA Biologics: Why The Dip To $16 Resets The Buy Case

2025-11-06 03:31:51 ET More on ADMA Biologics ADMA Biologics, Inc. (ADMA) Q3 2025 Earnings Call Transcript ADMA Biologics: Strong Product Mix, Growing Margins And Compelling Upside ADMA Biologics: Optionality With SG-001 And A Vertically Integrated IG Platform ...

2025-11-06 03:31:09 ET ADMA Biologics, Inc. (ADMA) Q3 2025 Earnings Call November 5, 2025 4:30 PM EST Company Participants Adam Grossman - Co-Founder, President, CEO & Director Brad Tade - CFO & Treasurer ... Read the full article on Seeking Alpha ...